Skip to main content

Datatrak International, Inc. and RadMD Partner to Provide End to End Medical Imaging Solution

CLEVELAND, OH, Sept. 29, 2020 (GLOBE NEWSWIRE) — via NewMediaWire –Datatrak International, Inc. (OTC Markets: DTRK), a worldwide Software-as-a-Service (“SaaS”) provider and innovation leader of cloud-based technologies for the life sciences industry, announces a new partnership with RadMD to leverage their professional services and enable their global network of radiologists with direct access to medical image assessments within a SaaS platform.
The Datatrak Enterprise Cloud Platform significantly reduces the time and cost of image assessments in clinical trials by eliminating the need for integrating redundant systems. Adhering to FDA guidance for image upload and centralized assessment, the platform was built to provide fast results. The intrinsic efficiencies make it more cost and time effective, enabling sponsors to make “live” go or no go decisions especially in early stage clinical trials. Datatrak is the first to automate Endpoint Adjudication and Picture Archiving and Communications processes within EDC as the last mile toward FDA approval submission. “The ability to automate remote image capture, PHI anonymization, image evaluation and endpoint adjudication, and provide eCRF data entry for AI data analytics meets the growing demands for imaging in clinical trials,” said Scott DeMell, VP Sales at Datatrak.“Our partnership with RadMD provides a global network of radiologists, with subspecialty therapeutic expertise, to design imaging strategies, interpret image reads, and perform adjudication reviews,” said Jim Bob Ward, CEO at Datatrak. “Performing these actions within our platform provides our clients’ higher quality of data standards and quicker visibility into imaging results. Group that with our ability to centralize all trial data and provide client-driven analytics, we are providing unprecedented visibility to make more informed and swift decisions.” “We look forward to partnering with Datatrak to support clients on independent image reviews with their leading edge platform and technologies,” said Kohkan Shamsi, MD, PhD, Co-founder and Principal at RadMD.  “Datatrak has a long track record in providing high quality SaaS tools, and the addition of imaging to their offering is truly exciting.”To learn more about Datatrak Medical Imaging Capture visit: https://bit.ly/2S5UZYaAbout Datatrak International, Inc.:Datatrak International is a worldwide technology and services company delivering unified eClinical solutions and related services for the clinical trials industry. Datatrak built its multi-component, comprehensive solution on a single, unified platform. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The Datatrak software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Pre-clinical, Phase I – Phase IV drug, device and diagnostic studies in multiple languages throughout the world.The Datatrak Enterprise Cloud includes the following products: Business Intelligence, CTMS, Trial Design, Electronic Data Capture (EDC), Medical Coding, Risk-Based Monitoring, ECG Data Capture, Image Data Capture, Endpoint Adjudication, Randomization, Clinical Supply Inventory, eConsent, ePRO, and eCOA.About RadMD: RadMD is an expertise based image management service organization that provides consulting, training, and independent imaging services to pharmaceutical, biotechnology, and medical device companies. RadMD has designed and created imaging endpoints and performed image reviews and analysis for >600 studies by largest pool of independent readers. RadMD has also and trained >1,000 sites to optimize image assessment.Jordan Regula
440-443-0082 x110
jordan.regula@datatrak.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.